Burkhard Blank is CMO and Head of R&D at ACORDA THERAPEUTICS INC (ACOR). They have made 5 open-market trades across 1 company since 2016, most recently 2025-07-15.
CIK 0001073409
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACOR | SELL | 2018-08-01 | 2018-08-03 | $24.69 | $309K | +7.1% | +8.2% | -22.7% |
| ACOR | SELL | 2018-07-02 | 2018-07-03 | $29.61 | $296K | +2.0% | -11.6% | -32.8% |
| ACOR | SELL | 2018-05-18 | 2018-05-22 | $23.66 | $592K | +15.1% | +30.6% | +23.8% |
| ACOR | SELL | 2017-12-01 | 2017-12-05 | $20.53 | $454K | +3.2% | +3.2% | +27.2% |
| ACOR | SELL | 2016-12-01 | 2016-12-05 | $20.74 | $415K | +0.7% | -3.5% | +27.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.